Delayed Contrast Extravasation MRI for Depicting Tumor and Non-Tumoral Tissues...


Yael Mardor, PhD from the Chaim Sheba Medical Center in Tel Aviv, Israel, discusses how delayed contrast extravasation magnetic resonance imaging (MRI) can be used to depict tumor and non-tumoral tissues in primary and secondary or metastatic brain tumors. She begins by explaining the method for acquiring the images for Contrast Clearance Assessment and how the resulting images can be analyzed to support the distinction between tumor progression and treatment effects. She then provides case examples to demonstrate the methodology and concludes with their findings.

About the speaker

Mardor Yael, PhD

Mardor Yael, PhD
The Chaim Medical Center, Israel

More clinical talks from this speaker

Related Videos

  • The Means for Radiosurgery Quality Management: Novalis Certified

    The Means for Radiosurgery Quality Management: Novalis Certified

    Timothy D. Solberg, PhD
    University of California San Francisco, San Francisco, USA
    Show video

  • Trajectory Based Treatment Planning and Delivery for Cranial Radiosurgery

    Trajectory Based Treatment Planning and Delivery for Cranial Radiosurgery

    James Robar, PhD
    Dalhousie University, Canada
    Show video

  • Reporting Clinical Outcomes via the NeuroPoint Alliance National...

    Reporting Clinical Outcomes via the NeuroPoint Alliance National...

    Robert E. Harbaugh, MD
    Penn State Milton S.Hershey Medical Center, USA
    Show video

  • Advanced MR and PET Imaging: Is it Really Useful in Brain Tumor Radiosurgery?

    Advanced MR and PET Imaging: Is it Really Useful in Brain Tumor Radiosurgery?

    Frederic Dhermain, MD, PhD
    Institut Gustave Roussy, France
    Show video

  • Image-guided Patient Monitoring Innovations

    Image-guided Patient Monitoring Innovations

    Christoph Bert, PhD
    Universitätsklink Erlangen, Germany
    Show video

  • Contrast Clearance Analysis for Differentiating Tumor From Treatment Effects

    Contrast Clearance Analysis for Differentiating Tumor From Treatment Effects

    Mardor Yael, PhD
    The Chaim Medical Center, Israel
    Show video

  • Value of Fibertracking for Target Definition and Pre-planning Requirements for Safe Thalamatomies

    Value of Fibertracking for Target Definition and Pre-planning Requirements for Safe Thalamatomies

    Ausaf Bari, MD
    UCLA Medical Center, USA
    Show video

  • Clinical Advantages of Elements with ExacTrac

    Clinical Advantages of Elements with ExacTrac

    Cory Knill, MS
    Beaumont Health, USA
    Show video


Back

Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.

WATCH Video

Keep Watching

Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.

  • Please read the following notice
    I have read the privacy policy. I agree that my information and data will be collected and stored electronically in order to answer my enquiry. Please note: You can revoke your consent at any time with effect for the future by emailing legal@brainlab.com.

Watch video No Thanks

Already Novalis Circle Member?

Member Login

Register now

Thank you for your interest in our Novalis Circle videos. Full-access to the media library is currently available for Novalis Radiosurgery users only. If you are a customer, please register or login to continue.

Register Now Login